Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Activity determination buffer solution and activity determination method of high-throughput Zika virus non-structural protease

A technology for Zika virus and activity determination, which is applied in the field of medicine to achieve the effect of improving activity and accurate results

Active Publication Date: 2017-02-22
TIANJIN INT JOINT ACADEMY OF BIOTECH & MEDICINE
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although most Zika virus-infected patients have mild symptoms and usually recover on their own after 3-7 days of onset, the medical community generally believes that this fast-spreading virus may be associated with an abnormally high number of newborns with microcephaly

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Activity determination buffer solution and activity determination method of high-throughput Zika virus non-structural protease
  • Activity determination buffer solution and activity determination method of high-throughput Zika virus non-structural protease
  • Activity determination buffer solution and activity determination method of high-throughput Zika virus non-structural protease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] The active assay buffer of high-throughput Zika virus nonstructural protease of the present invention, buffer component comprises: trishydroxymethylaminomethane 100mM, sodium chloride 20mM, the glycerol that volume fraction is 10%; The pH value of buffer is 8.0 .

[0037] The buffer has the effect of improving the activity of Zika virus non-structural protease.

Embodiment 2

[0039] The active assay buffer of high-throughput Zika virus non-structural protease of the present invention, buffer composition comprises: Tris 50mM, sodium chloride 10mM, CHAPS 0.5mM, galactose 10mM, volume fraction is the glycerol of 40% ; The pH value of the buffer is 8.5.

[0040] The buffer has the effect of improving the activity of Zika virus non-structural protease.

Embodiment 3

[0042] The active assay buffer of high-throughput Zika virus nonstructural protease of the present invention, buffer composition comprises: trishydroxymethylaminomethane 20mM, sodium chloride 5mM, CHAPS 1mM, galactose 20mM, the glycerol that volume fraction is 15%; The pH of the buffer was 8.7.

[0043] The buffer has the effect of improving the activity of Zika virus non-structural protease.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an activity determination buffer solution and an activity determination method of high-throughput Zika virus non-structural protease, wherein the buffer solution consists of the following buffer ingredients: 10-200mM of trihydroxymethyl aminomethane, 0-20mM of sodium chloride, 0-1mM of CHAPS, 0-20mM of galactose and glycerol which is 10-40% of in volume percentage, and the pH value of the buffer solution is at 8.0-9.0. The buffer solution provided by the invention can improve the activity of the protease in a process of detecting the enzymatic activity of Zika viruses, so that the high-throughput Zika virus non-structural protease activity determination method, which makes use of the buffer solution, is more accurate in result, and subsequently an effect of guiding the screening of Zika virus protease activity inhibitors is achieved and the research and development progress of medicines targeted to the Zika viruses is promoted.

Description

technical field [0001] The invention relates to the technical field of medicines, in particular to a high-throughput Zika virus non-structural protease activity assay buffer and an activity assay method. Background technique [0002] Zika virus (ZIKV) belongs to the Flaviviridae family (Fla.viviridae) and the genus Flavivirus. It is spherical in shape with a diameter of about 40-70 nm and has an envelope. Yellow fever virus belongs to the yellow fever virus genus of the yellow fever family. It is an RNA virus with viscerotropism and neurotropism. It is easy to die at room temperature. The genome is a single-stranded positive-strand RNA with a length of about 10.8Kb. The genome contains an open reading frame (ORF) encoding a polyprotein. [0003] Zika virus was first isolated in 1947 from macaques in the forests of Uganda. It was isolated from the human body for the first time in 1952. As of the end of the last century, Zika virus infection was thought to be distributed on...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/37
CPCC12Q1/37
Inventor 杨海涛胡灿陈成王泽方蔡岩
Owner TIANJIN INT JOINT ACADEMY OF BIOTECH & MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products